• $439,200.00
    Market Cap
  • N/A
    1-Year Change
  • Household & Personal Products
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH

Rosen Law Firm has filed class action lawsuits against Park Ha Biological Technology Co., Ltd. (PHH, BYAH) for securities fraud involving false statements and undisclosed fraudulent stock promotion schemes during December 2024-July 2025. A separate lawsuit targets GRAIL, Inc. (GRAL) with an August 4, 2026 deadline for investors to secure counsel. Both cases allege material misstatements and failure to disclose adverse facts affecting stock prices.

08/01/2026, 2:58 PM • GlobeNewswire

BYAH Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Park Ha Biological Technology Co., Ltd. Class Action

Robbins LLP announces a securities class action lawsuit against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) for allegedly being subject to a market manipulation and pump-and-dump scheme involving social media misinformation and impersonated financial professionals. The company failed to disclose material risks associated with the scheme. Park Ha's stock surged from $4.00 to $41.49 before collapsing 93% to $2.99 on July 8, 2025, wiping out over $1 billion in market value. The lead plaintiff deadline is September 28, 2026.

07/31/2026, 8:23 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) alleging securities fraud. The complaint claims the company made false and misleading statements, failed to disclose a fraudulent stock promotion and market manipulation scheme involving social media misinformation, and intentionally structured its IPO with an extremely low public float to facilitate manipulation. Investors who purchased securities between December 27, 2024 and July 8, 2025 can join the case, with a lead plaintiff deadline of September 21, 2026.

07/30/2026, 12:36 PM • GlobeNewswire

Park Ha Biological Technology (BYAH) Stock Surges Over 41% After Hours: Why Is It Moving?

Park Ha Biological Technology (NASDAQ: BYAH) shares jumped 41.66% to $1.70 in after-hours trading following the closing of a $2.0 million registered direct offering. The stock had dropped 20% during regular trading to $1.20. The company also announced a strategic AI-driven skincare partnership with Star Plus Action. Despite the after-hours surge, BYAH has declined 99.89% over the past 12 months and remains near its annual low, indicating continued investor pressure.

06/18/2026, 12:27 AM • Benzinga

Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering

Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) announced a registered direct offering of up to 1,133,332 Class A ordinary shares and pre-funded warrants to purchase 200,000 shares at $1.50 per unit, expected to raise approximately $2.0 million. The offering is expected to close on June 15, 2026, with net proceeds designated for general corporate and working capital purposes. D. Boral Capital LLC is serving as the sole placement agent.

06/12/2026, 2:54 PM • GlobeNewswire

Why Is Park Ha Biological Technology Rocketing On Friday?

Park Ha Biological Technology (NASDAQ: BYAH) announced a strategic partnership with Star Plus Action to innovate in healthcare and skincare sectors through AI integration. The collaboration aims to create an intelligent service ecosystem in the beauty and wellness industry. BYAH shares surged 133% to $2.45 on Friday following the announcement.

06/12/2026, 10:47 AM • Benzinga

INVESTOR ALERT: Morris Kandinov LLP Investigating PHH, WAI, PCLA, and EPWK; Stockholders are Encouraged to Contact the Firm

Law firm investigating potential pump-and-dump schemes involving multiple securities, with scammers using WhatsApp groups and fraudulent social media ads to solicit victims.

08/08/2025, 2:19 PM • GlobeNewswire

Peers

Statistics

More
Day Range
$0.33
$0.40
$0.35
1-Year Range
$0.05
$2.65
$0.35
Latest Close$0.35
Change
-$0.01 (-3.21%)
Volume1,226,541
Market Cap$439,200.00
Shares Outstanding1.2M
P/E (TTM)-0.0002
Diluted EPS (TTM)-$2,069.00
Enterprise Value-$3.3M

Information as of 08/03/2026

Company Profile

PARK HA BIOLOGICAL TECHNOLOGY CO LTD
https://parkha.cn
$439,200.00
Market Cap
-$24.4M
Net Income
Sector: Consumer Defensive
Industry: Household & Personal Products
Building C, Wuxi, China, 214100
86 40 0012 7562

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. It operates in two segments, Product Sales and Franchise Service. The company offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company has a strategic partnership with Star Plus Action (HK) Limited to build an AI-powered skincare and health ecosystem and expand its healthcare reach. Park Ha Biological Technology Co., Ltd. has strategic partnership with Cloud Factory Technology Holdings Limited to build ai-driven ecosystem for the beauty industry. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.

Key Executives

  • Xiaoqiu Zhang
  • Xiaoyan Zhu
  • Xinyu Li

Current Ownership Distribution

  • Insiders384,438 (56.75%)
  • Other292,926 (43.24%)
  • Institutions96 (0.01%)
  • Mutual Funds0 (0.00%)